1
MSc Student, Department of Exercise Physiology, School of Physical Education, Shahid Chamran University, Ahvaz, Iran
2
Associate Professor, Musculoskeletal Rehabilitation Research Center AND Department of Neurology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3
Assistant Professor, Department of Exercise Physiology, School of Physical Education, Shahid Chamran University, Ahvaz, Iran
Abstract
Background: Multiple sclerosis (MS) is a demyelinating autoimmune disease, with an unclear mechanism, and characterized by axonal damage, demyelination and increase inflammatory. Recently, it has been found that leptin plays a role in the pathogenesis of multiple sclerosis. The current study aimed to compare serum level of leptin and aerobic capacity in relapsing and remitting duration in women with multiple sclerosis.Methods: 32 women with multiple sclerosis including 12 in relapsing and 20 in remitting phases participated in this study. Serum level of leptin was assessed using enzyme-linked immunosorbent assay (ELISA) kit and aerobic capacity was measured using ergometer cycle incremental test. Independent t and Pearson correlation tests were used for data analysis at the significant level of P ≤ 0.05.Findings: Data indicated that leptin was higher in relapsing group; but, aerobic capacity was higher in remitting group (P ≤ 0.05). In addition, a negative and significant correlation was observed between leptin and aerobic capacity in both groups and leptin and body mass index in remitting group (P ≤ 0.05).Conclusion: According to the result, increasing of leptin and decreasing of aerobic capacity associated with relapsing in patients with relapsing-remitting multiple sclerosis.
Styne DM. Childhood and adolescent obesity. Prevalence and significance. Pediatr Clin North Am 2001; 48(4): 823-54, vii.
Zhang Y, Scarpace PJ. The role of leptin in leptin resistance and obesity. Physiol Behav 2006; 88(3): 249-56.
Najmi M, Hajifaraji M, Abd Mishani M. The Effect of adipokines secreted from adipose tissue on immune function in obese subjects. Iran J Nutr Sci Food Technol 2013; 7 (5): 887-96. [In Persian].
Teryaeva NB. Leptin as a Neuroprotector and a central nervous system functional stability factor. Neurosci Behav Physiol 2015; 45(6): 612-8.
Langeskov-Christensen M, Heine M, Kwakkel G, Dalgas U. Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis. Sports Med 2015; 45(6): 905-23.
Storer TW, Davis JA, Caiozzo VJ. Accurate prediction of VO2max in cycle ergometry. Med Sci Sports Exerc 1990; 22(5): 704-12.
Kraszula L, Jasinska A, Eusebio M, Kuna P, Glabinski A, Pietruczuk M. Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis. Neurol Neurochir Pol 2012; 46(1): 22-8.
Correale J, Aguirre MEB, Farez M. Body mass index and multiple sclerosis risk. The role of leptin. Neurology 2014; 82(10 Suppl): S24.004.
Matarese G, Procaccini C, De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J Leukoc Biol 2008; 84(4): 893-9.
Procaccini C, Pucino V, Mantzoros CS, Matarese G. Leptin in autoimmune diseases. Metabolism 2015; 64(1): 92-104.
Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001; 166(10): 5909-16.
Batocchi AP, Rotondi M, Caggiula M, Frisullo G, Odoardi F, Nociti V, et al. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003; 139(1-2): 150-4.
Frisullo G, Angelucci F, Mirabella M, Caggiula M, Patanella K, Nociti V, et al. Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients. J Clin Immunol 2004; 24(3): 287-93.
Masoudinejad M, Shirvani H. Effect of selected combined training program on leptin serum level of men with multiple sclerosis. Journal of Exercise Physiology and Physical Activity 2011; 4(1): 545-53. [In Persian].
Mokhtarzadeh, M., Majdinasab, N., Negaresh, R. & Ranjbar, R. (2016). Association of Relapse of Multiple Sclerosis with Increased Serum Levels of Leptin and Decreased Aerobic Capacity in Women. Journal of Isfahan Medical School, 34(403), 1251–1255.
MLA
Mokhtarzadeh, M., Majdinasab, N., Negaresh, R., & Ranjbar, R. "Association of Relapse of Multiple Sclerosis with Increased Serum Levels of Leptin and Decreased Aerobic Capacity in Women", Journal of Isfahan Medical School, 34, 403, 2016, 1251–1255.
HARVARD
Mokhtarzadeh, M., Majdinasab, N., Negaresh, R., & Ranjbar, R. (2016). 'Association of Relapse of Multiple Sclerosis with Increased Serum Levels of Leptin and Decreased Aerobic Capacity in Women', Journal of Isfahan Medical School, 34(403), pp. 1251–1255.
CHICAGO
Mokhtarzadeh, M., Majdinasab, N., Negaresh, R. & Ranjbar, R., "Association of Relapse of Multiple Sclerosis with Increased Serum Levels of Leptin and Decreased Aerobic Capacity in Women." Journal of Isfahan Medical School, 34 403 (2016): 1251–1255,
VANCOUVER
Mokhtarzadeh M., Majdinasab N., Negaresh R., Ranjbar R. Association of Relapse of Multiple Sclerosis with Increased Serum Levels of Leptin and Decreased Aerobic Capacity in Women. JIMS. 2016;34(403):1251–1255 (In Persian).
